Artificial corneas versus donor corneas for repeat corneal transplants

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 11, 2014, Pages

  Akpek, Esen K ^a   Alkharashi, Majed ^b   Hwang, Frank S ^c   Ng, Sueko M ^d   Lindsley, Kristina ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c WAYNE STATE UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL CORNEA; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CORNEA; CORNEA TRANSPLANTATION; DONOR; GRAFT FAILURE; HUMAN; PATIENT CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VISION; ADULT; ARTIFICIAL ORGAN; REOPERATION;

ADULT; ARTIFICIAL ORGANS; CORNEA; CORNEAL TRANSPLANTATION; HUMANS; REOPERATION;

EID: 84943614505     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009561.pub2     Document Type: Review

References (66)

1. Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 2009;116(4):640-51.
2. Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, et al.International results with the Boston type I keratoprosthesis. Ophthalmology 2012;119(8):1530-8.
3. Goldman DR, Hubschman JP, Aldave AJ, Chiang A, Huang JS, Bourges JL, et al.Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina 2013;33(3):532-41.
4. Kim MJ, Yu F, Aldave AJ. Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes. Ophthalmology 2013;120(11):2209-16.
5. Sejpal K, Yu F, Aldave AJ. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency. Cornea 2011;30(11):1187-94.
6. Aldave AJ, Sangwan VS, Basu S, Basak SK, Hovakimyan A, Gevorgyan O, et al.International results with the Boston type I keratoprosthesis. Ophthalmology 2012;119(8):1530-8.
7. Aquavella JV, Qian Y, McCormick GJ, Palakuru JR. Keratoprosthesis: current techniques. Cornea 2006;25(6):656-62.
8. Aquavella JV, Qian Y, McCormick GJ, Palakuru JR. Keratoprosthesis: the Dohlman-Doane device. American Journal of Ophthalmology 2005;140(6):1032-8.
9. Ament JD, Stryjewski TP, Ciolino JB, Todani A, Chodosh J, Dohlman CH. Cost-effectiveness of the Boston keratoprosthesis. American Journal of Ophthalmology 2010;149(2):221-8.
10. Ciolino JB, Belin MW, Todani A, Al-Arfaj K, Rudnisky CJ, Boston Type 1 Keratoprosthesis Study Group. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2013;120(6):1195-200.
11. Rudnisky CJ, Belin MW, Todani A, Al-Arfaj K, Ament JD, Zerbe BJ, et al.Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2012;119(5):951-5.
12. Zerbe BL, Belin MW, Ciolino JB, Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 2006;113(10):1779.e1-7.
13. Chew HF, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, et al.Boston keratoprosthesis outcomes and complications. Cornea 2009;28(9):989-96.
14. Akpek EK, Harissi-Dagher M, Petrarca R, Butrus SI, Pineda R 2nd, Aquavella JV, et al.Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. American Journal of Ophthalmology 2007;144(2):227-31.
15. Dunlap K, Chak G, Aquavella JV, Myrowitz E, Utine CA, Akpek E. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology 2010;117(4):687-92.
16. Khan BF, Harissi-Dagher M, Pavan-Langston D, Aquavella JV, Dohlman CH. The Boston keratoprosthesis in herpetic keratitis. Archives of Ophthalmology 2007;125(6):745-9.
17. Ghaffariyeh A, Honarpisheh N, Karkhaneh A, Abudi R, Moroz ZI, Peyman A, et al.Fyodorov-Zuev keratoprosthesis implantation: long-term results in patients with multiple failed corneal grafts. Graefes Archive for Clinical and Experimental Ophthalmology 2011;249(1):93-101.
18. Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea 2009;28(3):321-7.
19. Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology 2011;118(8):1543-50.
20. Shapiro BL, Cortes DE, Chin EK, Li JY, Werner JS, Redenbo E, et al.High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis. Cornea 2013;32(7):951-5.
21. Guell JL, Arcos E, Gris O, Aristizabal D, Pacheco M, Sanchez CL, et al.Outcomes with the Boston Type 1 Keratoprosthesis at Instituto de Microcirugia Ocular IMO. Saudi Journal of Ophthalmology 2011;25(3):281-4.
22. Verdejo-Gomez L, Pelaez N, Gris O, Guell JL. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety. Ophthalmic Surgery, Lasers and Imaging 2011;42(6):446-52.
23. Harissi-Dagher M, Dohlman CH. The Boston keratoprosthesis in severe ocular trauma. Canadian Journal of Ophthalmology 2008;43(2):165-9.
24. Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea 2007;26(5):564-8.
25. Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Archives of Ophthalmology 2001;119(4):484-9.
26. Sayegh RR, Ang LP, Foster CS, Dohlman CH. The Boston keratoprosthesis in Stevens-Johnson syndrome. American Journal of Ophthalmology 2008;145(3):438-44.
27. Yaghouti F, Nouri M, Abad JC, Power WJ, Doane MG, Dohlman CH. Keratoprosthesis: preoperative prognostic categories. Cornea 2001;20(1):19-23.
28. Crawford GJ, Hicks CR, Lou X, Vijayasekaran S, Tan D, Mulholland B, et al.The Chirila keratoprosthesis: phase I human clinical trial. Ophthalmology 2002;109(5):883-9.
29. Hicks CR, Crawford GJ, Dart JK, Grabner G, Holland EJ, Stulting RD, et al.AlphaCor: Clinical outcomes. Cornea 2006;25(9):1034-42.
30. Hicks CR, Crawford GJ, Lou X, Tan DT, Snibson GR, Sutton G, et al.Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications. Eye 2003;17(3):385-92.
31. Hicks CR, Crawford GJ, Tan DT, Snibson GR, Sutton GL, Gondhowiardjo TD, et al.Outcomes of implantation of an artificial cornea, AlphaCor: effects of prior ocular herpes simplex infection. Cornea 2002;21(7):685-90.
32. Hicks CR, Macvie O, Crawford GJ, Constable IJ. A risk score as part of an evidence-based approach to the selection of corneal replacement surgery. Cornea 2005;24(5):523-30.
33. Hille K, Hille A, Ruprecht KW. Medium term results in keratoprostheses with biocompatible and biological haptic. Graefes Archive for Clinical and Experimental Ophthalmology 2006;244(6):696-704.
34. Jiraskova N, Rozsival P, Burova M, Kalfertova M. AlphaCor artificial cornea: clinical outcome. Eye 2011;25(9):1138-46.
35. Kamyar R, Weizer JS, de Paula FH, Stein JD, Moroi SE, John D, et al.Glaucoma associated with Boston type I keratoprosthesis. Cornea 2012;31(2):134-9.
36. Koller B, Neuhann T, Neuhann I. Results with the Boston keratoprosthesis. Ophthalmologe 2012;109(5):454-61.
37. Patel AP, Wu EI, Ritterband DC, Seedor JA. Boston type 1 keratoprosthesis: the New York Eye and Ear experience. Eye 2012;26(3):418-25.
38. Shihadeh WA, Mohidat HM. Outcomes of the Boston keratoprosthesis in Jordan. Middle East African Journal of Ophthalmology 2012;19(1):97-100.
39. Robert MC, Biernacki K, Harissi-Dagher M. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers. Cornea 2012;31(4):339-45.
40. Robert MC, Harissi-Dagher M. Boston type 1 keratoprosthesis: the CHUM experience. Canadian Journal of Ophthalmology 2011;46(2):164-8.
41. Talajic JC, Agoumi Y, Gagne S, Moussally K, Harissi-Dagher M. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery. American Journal of Ophthalmology 2012;153(2):267-74.
42. Trichet E, Carles G, Matonti F, Proust H, Ridings B, Conrath J, et al.Alphacor keratoprosthesis: device, surgical technique and clinical outcomes. Journal Francais d'Opthalmologie 2013;36(5):393-401.
43. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern® Guidelines. Corneal edema and opacification. www.aao.org/ppp (accessed 6 February 2014).
44. The Australian Corneal Graft Registry. 1990 to 1992 report. Australian and New Zealand Journal of Ophthalmology 1993;21(2 Suppl):1-48.
45. Ament JD, Stryjewski TP, Ciolino JB, Todani A, Chodosh J, Dohlman CH. Cost-effectiveness of the Boston keratoprosthesis. American Journal of Ophthalmology 2010;149(2):221-8.
46. Bersudsky V, Blum-Hareuveni T, Rehany U, Rumelt S. The profile of repeated corneal transplantation. Ophthalmology 2001;108(3):461-9.
47. Eye Bank Association of America. 2013 Eye banking statistical report. www.restoresight.org/wp-content/uploads/2014/04/2013_Statistical_Report-FINAL.pdf (accessed 3 February 2014).
48. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
49. Ilhan-Sarac O, Akpek EK. Current concepts and techniques in keratoprosthesis. Current Opinion in Ophthalmology 2005;16(4):246-50.
50. KPro Study Group. Bibliography of keratoprosthesis and artificial cornea and biomaterials therefor 1789 to 2013. www.kpro.org (accessed 28 August 2013).
51. Ma JJ, Graney JM, Dohlman CH. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. International Ophthalmology Clinics 2005;45(4):49-59.
52. Massachusetts Eye, Ear Infirmary. Boston KPro news. Newsletter IX: 2013. www.masseyeandear.org/gedownload!/Kpro-News-Vol9-Aug-2013.pdf?item_id=74892044&version_id=74892045 (accessed 23 November 2013).
53. Michael R, Charoenrook V, de la Paz MF, Hitzl W, Temprano J, Barraquer RI. Long-term functional and anatomical results of osteo-and osteoodonto-keratoprosthesis. Graefes Archive for Clinical and Experimental Ophthalmology 2008;246(8):1133-7.
54. Murthy GVS, Johnson GJ. Chapter 1: prevalence, incidence and distribution of visual impairment. In: Johnson GJ, Minassian DC, Weale RA, West SK editor(s). The Epidemiology of Eye Disease. III Edition. Imperial College Press, 2012.
55. Reeves BC, Deeks JJ, Higgins JPT, Wells GA. Chapter 13: Including non-randomized studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
56. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
57. Siganos CS, Tsiklis NS, Miltsakakis DG, Georgiadis NS, Georgiadou IN, Kymionis GD, et al.Changing indications for penetrating keratoplasty in Greece, 1982-2006: a multicenter study. Cornea 2010;29(4):372-4.
58. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr. Long-term graft survival after penetrating keratoplasty. Ophthalmology 2003;110(7):1396-402.
59. Todani A, Ciolino JB, Ament JD, Colby KA, Pineda R, Belin MW, et al.Titanium back plate for a PMMA keratoprosthesis: clinical outcomes. Graefes Archive for Clinical and Experimental Ophthalmology 2011;249(10):1515-8.
60. Utine CA, Tzu J, Dunlap K, Akpek EK. Visual and clinical outcomes of explantation versus preservation of the intraocular lens during keratoprosthesis implantation. Journal of Cataract and Refractive Surgery 2011;37(9):1615-22.
61. Wagoner MD, Gonnah el-S, Al-Towerki AE, King Khaled Eye Specialist Hospital Cornea Transplant Study Group. Outcome of primary adult penetrating keratoplasty in a Saudi Arabian population. Cornea 2009;28(8):882-90.
62. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bulletin of the World Health Organization 2001;79(3):214-21.
63. Williams KA, Muehlberg SM, Lewis RF, Coster DJ. How successful is corneal transplantation? A report from the Australian Corneal Graft Register. Eye 1995;9(Pt 2):219-27.
64. Yildiz EH, Hoskins E, Fram N, Rapuano CJ, Hammersmith KM, Laibson PR, et al.Third or greater penetrating keratoplasties: indications, survival, and visual outcomes. Cornea 2010;29(3):254-9.
65. Zerbe BL, Belin MW, Ciolino JB, Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 2006;113(10):1779.
66. Akpek EK, Alkharashi M, Lindsley K. Artificial corneas versus donor corneas for repeat corneal transplants. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD009561]